BackConduit Pharmaceuticals Overview

Conduit Pharmaceuticals Current Cash

Track Conduit Pharmaceuticals's current cash ($350M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$348.65M
↑ 15.65% YoYΔ $47.17M vs prior year quarter

Peer trimmed avg / median

Loading

Conduit Pharmaceuticals Current Cash History

Loading

Conduit Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Conduit Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Conduit Pharmaceuticals (CDT) FAQ

As of the most recent data (June 2026), CDT shows a current cash of $350M. That compares with $300M in the prior-year period — up 15.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, CDT's current cash is now $350M (was $300M) — a 15.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Conduit Pharmaceuticals is outperforming or lagging.

Tracking CDT's current cash over time shows whether Conduit Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $350M That compares with $300M in the prior-year period — up 15.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Conduit Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $350M) with ownership activity and broader fundamentals.